
Tetrahedron Letters p. 813 - 816 (1998)
Update date:2022-07-30
Topics:
Hillebrand, Stefan
Bartkowska, Beata
Bruckmann, Joachim
Krueger, Carl
Haenel, Matthias W.
Reaction of 4,5-difluoroacridine (8) with two equivalents of potassium diphenylphosphide (Ph2PK) yielded the title compound 3. Contrarily, diphenylphosphine (Ph2PH) reacted with 8 under addition, and 4,5-difluoro-9-diphenyl-9,10-dihydroacridine (12) was obtained. Compound 8 was prepared from 2-amino-3-fluorobenzoic acid (13) in a four step synthesis. As it is shown by the preparation of the metal complexes 4,5-bis(diphenylphosphino)-acridine-palladium dichloride (16) and 4,5-bis(diphenylphosphino)acridine-molybdenum tricarbonyl (17), compound 3 is capable of acting as a tridentate PNP ligand which coordinates transition metals in an approximately 'T-shaped' planar coordination geometry. Single crystal X-ray structure analyses we reported for 3 and 17.
View MoreTianjin Chemsyntech Chemical Co., Ltd
Contact:+86-22-60872258
Address:Haitai green industry base in Tianjin, K1,5-601
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
GUANGXI GUANGHONG PHARMACEUTICAL CO.,LTD
website:http://www.irondextran-factory.com
Contact:+8618928624811
Address:No.7 Baota Road, Baota Pharmaceutical Industry Park, Long’an, Nanning, China
Hubei Jiutian Bio-medical Technology Co., Ltd
website:http://www.jiutian-bio.com
Contact:+86-027-88013699
Address:Room 03-6, 5th floor, building 1, international enterprise center phase iii, no. 1, guanggu avenue, east lake new technology development zone, wuhan city
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Doi:10.1016/S0022-1139(97)00119-X
(1998)Doi:10.1107/S0108270197012985
(1998)Doi:10.1021/tx970205u
(1998)Doi:10.1039/DT9920001967
(1992)Doi:10.1055/s-1998-1621
(1998)Doi:10.1021/ja407407h
(2013)